These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 32974366)

  • 1. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
    Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
    Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.
    Díaz LA; Arab JP; Louvet A; Bataller R; Arrese M
    Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):764-783. PubMed ID: 37582985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
    Craciun A; Lackner C; Cortez-Pinto H
    Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
    Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges.
    Hashimoto E; Tokushige K; Ludwig J
    Hepatol Res; 2015 Jan; 45(1):20-8. PubMed ID: 24661406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).
    Choudhary NS; Duseja A
    Transl Gastroenterol Hepatol; 2021; 6():2. PubMed ID: 33409397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
    Mahli A; Hellerbrand C
    Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis.
    Sharma P; Arora A
    Transl Gastroenterol Hepatol; 2020; 5():19. PubMed ID: 32258523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).
    Seitz HK; Mueller S; Hellerbrand C; Liangpunsakul S
    Hepatobiliary Surg Nutr; 2015 Jun; 4(3):147-51. PubMed ID: 26151054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
    Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
    J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease.
    Åberg F; Puukka P; Salomaa V; Männistö S; Lundqvist A; Valsta L; Perola M; Jula A; Färkkilä M
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):995-997.e2. PubMed ID: 31255807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.
    Ayonrinde OT
    JHEP Rep; 2021 Jun; 3(3):100261. PubMed ID: 34036255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.
    Mishra A; Younossi ZM
    J Clin Exp Hepatol; 2012 Jun; 2(2):135-44. PubMed ID: 25755422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.